Case Reports
Prenatal testing for late infantile neuronal ceroid lipofuscinosis
Affiliations
- PMID: 10665500
Item in Clipboard
Case Reports
Prenatal testing for late infantile neuronal ceroid lipofuscinosis
Ann Neurol.
2000 Feb.
Abstract
Classic late infantile neuronal ceroid lipofuscinosis (LINCL) is a neurodegenerative disease in which autofluorescent "curvilinear" storage bodies accumulate in tissues from affected patients. Recently, the LINCL gene (CLN2) has been found to code for a pepstatin-insensitive lysosomal protease whose activity is deficient in LINCL specimens. We report the first 2 cases of successful prenatal testing for LINCL by using DNA and enzyme-based methods on amniocytes, and describe a new private mutation in one of the families analyzed. These approaches allow definitive prenatal diagnosis and represent a significant improvement over previous pathological methods.
Similar articles
-
Late infantile neuronal ceroid lipofuscinosis is due to splicing mutations in the CLN2 gene.Mol Genet Metab. 1999 Jun;67(2):162-8. doi: 10.1006/mgme.1999.2853. Mol Genet Metab. 1999. PMID: 10356316
-
R208X mutation in CLN2 gene associated with reduced cerebrospinal fluid pterins in a girl with classic late infantile neuronal ceroid lipofuscinosis.Croat Med J. 2003 Aug;44(4):489-93. Croat Med J. 2003. PMID: 12950156
-
Biochemical characterization of a lysosomal protease deficient in classical late infantile neuronal ceroid lipofuscinosis (LINCL) and development of an enzyme-based assay for diagnosis and exclusion of LINCL in human specimens and animal models.J Neurochem. 1999 Aug;73(2):700-11. doi: 10.1046/j.1471-4159.1999.0730700.x. J Neurochem. 1999. PMID: 10428067
-
Neuronal ceroid lipofuscinoses and possible pathogenic mechanism.Mol Genet Metab. 2000 Sep-Oct;71(1-2):195-206. doi: 10.1006/mgme.2000.3057. Mol Genet Metab. 2000. PMID: 11001811 Review.
-
[Jansky-Bielschowsky disease].Ryoikibetsu Shokogun Shirizu. 2002;(37 Pt 6):252-4. Ryoikibetsu Shokogun Shirizu. 2002. PMID: 12483874 Review. Japanese. No abstract available.
Cited by
-
Guidelines on the diagnosis, clinical assessments, treatment and management for CLN2 disease patients.Orphanet J Rare Dis. 2021 Apr 21;16(1):185. doi: 10.1186/s13023-021-01813-5. Orphanet J Rare Dis. 2021. PMID: 33882967 Free PMC article.
-
Mutation update: Review of TPP1 gene variants associated with neuronal ceroid lipofuscinosis CLN2 disease.Hum Mutat. 2019 Nov;40(11):1924-1938. doi: 10.1002/humu.23860. Epub 2019 Jul 26. Hum Mutat. 2019. PMID: 31283065 Free PMC article.
-
Batten disease: biochemical and molecular characterization revealing novel PPT1 and TPP1 gene mutations in Indian patients.BMC Neurol. 2018 Dec 12;18(1):203. doi: 10.1186/s12883-018-1206-1. BMC Neurol. 2018. PMID: 30541466 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
